Difference between revisions of "John Eden"
| Line 1: | Line 1: | ||
{{Template:Pharma_Portal_badge}} | {{Template:Pharma_Portal_badge}} | ||
| − | Dr. [[John Eden]] is Director of the Barbara Gross Research Unit, the Sydney Menopause Centre and the Natural Therapies Unit. He is Associate Professor of Reproductive Endocrinology at the University of New South Wales.<ref>SMC.[http://web.med.unsw.edu.au/o&g/bgru_smc/bgru_smc_staff.htm Staff: Sydney Menopause Centre] Accessed 6 March 2010.</ref> Eden | + | Dr. [[John Eden]] is Director of the Barbara Gross Research Unit, the Sydney Menopause Centre and the Natural Therapies Unit. He is Associate Professor of Reproductive Endocrinology at the University of New South Wales.<ref>SMC.[http://web.med.unsw.edu.au/o&g/bgru_smc/bgru_smc_staff.htm Staff: Sydney Menopause Centre] Accessed 6 March 2010.</ref> Eden was accused of signing his name to a paper ghostwritten by [[Wyeth]], manufacturer of hormone replacement therapy (HRT), [[Prempro]], and the medical communications company [[DesignWrite]].<ref>Wilson, D. 12 December 2008. ''The New York Times. '' [http://www.nytimes.com/2008/12/12/business/13wyeth.html?_r=1 Drug Maker Said to Pay Ghostwriters for Journal Articles] Accessed 6 March 2010.</ref> |
=='Deceived' by a drug company== | =='Deceived' by a drug company== | ||
| − | In April 2010, Eden claimed [[Wyeth]] 'had misled him about its real agenda and its behind-the-scenes role in his paper' published by [[American Journal of Obstetrics and Gynecology]]. | + | In April 2010, Eden claimed [[Wyeth]] 'had misled him about its real agenda and its behind-the-scenes role in his paper' published by [[American Journal of Obstetrics and Gynecology]]. Following a US Sentate investigation spearheaded by Senator Chuck Grassley,<ref>Wilson, D. 12 December 2008. ''New York Times.'' [http://www.nytimes.com/2008/12/12/business/13wyeth.html?_r=1 Drug Maker Said to Pay Ghostwriters for Journal Articles] Accessed 4 April 2010.</ref> the doctor was cleared of the accusation that 'ghostwriters' paid by the drug company had written his paper. However, internal documents show how a Wyeth representative proposed the use of "knowledgeable and gifted writers" in drafting the manuscript for publication; came up with the paper's title; and [[DesignWrite]] paid a freelance science writer close to £2000 to draft an 11-page "outline" which was examined by Wyeth's marketing department before being sent to Eden. The drug company's assistance was not acknowledged in the publication.<ref>Guilliatt, R. 3 April 2010. ''The Australian.'' [http://www.theaustralian.com.au/news/health-science/scientist-deceived-by-drugs-giant/story-e6frg8y6-1225849066072 Scientist `deceived' by drugs giant] Accessed 4 April 2010.</ref> |
==Resources== | ==Resources== | ||
| − | *See [[Ghostwriting]] | + | *See [[DesignWrite]] and [[Ghostwriting]] for more details. |
==Notes== | ==Notes== | ||
Revision as of 20:46, 4 April 2010
|
This article is part of the Pharma_Portal project of Spinwatch. |
Dr. John Eden is Director of the Barbara Gross Research Unit, the Sydney Menopause Centre and the Natural Therapies Unit. He is Associate Professor of Reproductive Endocrinology at the University of New South Wales.[1] Eden was accused of signing his name to a paper ghostwritten by Wyeth, manufacturer of hormone replacement therapy (HRT), Prempro, and the medical communications company DesignWrite.[2]
'Deceived' by a drug company
In April 2010, Eden claimed Wyeth 'had misled him about its real agenda and its behind-the-scenes role in his paper' published by American Journal of Obstetrics and Gynecology. Following a US Sentate investigation spearheaded by Senator Chuck Grassley,[3] the doctor was cleared of the accusation that 'ghostwriters' paid by the drug company had written his paper. However, internal documents show how a Wyeth representative proposed the use of "knowledgeable and gifted writers" in drafting the manuscript for publication; came up with the paper's title; and DesignWrite paid a freelance science writer close to £2000 to draft an 11-page "outline" which was examined by Wyeth's marketing department before being sent to Eden. The drug company's assistance was not acknowledged in the publication.[4]
Resources
- See DesignWrite and Ghostwriting for more details.
Notes
- ↑ SMC.Staff: Sydney Menopause Centre Accessed 6 March 2010.
- ↑ Wilson, D. 12 December 2008. The New York Times. Drug Maker Said to Pay Ghostwriters for Journal Articles Accessed 6 March 2010.
- ↑ Wilson, D. 12 December 2008. New York Times. Drug Maker Said to Pay Ghostwriters for Journal Articles Accessed 4 April 2010.
- ↑ Guilliatt, R. 3 April 2010. The Australian. Scientist `deceived' by drugs giant Accessed 4 April 2010.
